Dose-levels and first signs of efficacy in contemporary oncology phase 1 clinical trials.

por Charles Ferte, Jean-Charles Soria, Nicolas Penel
Publicado 2011

Predictive value of clinical judgment of tumour progression in phase II trials.

por Nuria Kotecki, Nicolas Penel, Antoine Adenis, Charles Ferte, Stéphanie Clisant
Publicado 2012

Development and validation of a bedside score to predict early death in cancer of unknown primary patients.

por Nicolas Penel, Sylvie Negrier, Isabelle Ray-Coquard, Charles Ferte, Patrick Devos, Antoine Hollebecque, Michael B Sawyer, Antoine Adenis, Pascal Seve
Publicado 2009

Avelumab for platinum-ineligible/refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck: phase Ib results from the JAVELIN Solid Tumor trial

por Nicolas Penel, Ulrich Keilholz, Ani Balmanoukian, Manish R Patel, Sanjay Goel, Keun-Wook Lee, Alain Mita, Christophe Le Tourneau, Deborah J Wong, Patrick Schöffski, Marcis Bajars, Amaury Daste, Hans Juergen Grote, Dongli Zhou, Michael S Gordon, Martin Gutierrez, Damien Vansteene, Joël Guigay
Publicado 2021